| Roche Pharma (Schweiz) AG - Phesgo 1200 mg/600 mg/15 ml, Injektionslösung | | 67828 | | 02 | | Phesgo 1200 mg/600 mg/15 ml | | Injektionslösung | | L01FY01 | | | | 08.04.2021 | | |
| | Composition | | pertuzumabum 1200 mg, trastuzumabum 600 mg, hyaluronidasum humanum ADNr, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, saccharum, polysorbatum 20, dl-methioninum, aqua ad iniectabile q.s. ad solutionem pro 15 ml. | | Packungsbestandteile | | Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Pertuzumabum | 1200mg / 15ml | | Trastuzumab | 600mg / 15ml |
| | BAG: Principe actif | Concentr. |
|---|
| Pertuzumabum | 1200 mg | | Trastuzumab | 600 mg |
| | | | Agents auxilliaires |
|---|
| DL-Methionine | | Histidin Hydrochloride Monohydrate | | Histidine | | Hyaluronidasum Humanum Adnr | | Polysorbatum 20 | | Saccharum | | Trehalosum Dihydricum |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | | 5759.61 | 6217.15 | A | LS | Non |
|
|
